TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1464321
log Bayes Factor = 0.988433
Chromosome 12   position 103,656,233  (GRCh37) Explore rs1464321 on Ensembl!
Variant rs1464321 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.084 0.916
E03 Other hypothyroidism
0.000 0.713 0.287
E03.5 Myxoedema coma
0.000 0.794 0.206
E03.4 Atrophy of thyroid (acquired)
0.000 0.794 0.206
E03.3 Postinfectious hypothyroidism
0.000 0.794 0.206
E03.1 Congenital hypothyroidism without goitre
0.000 0.794 0.206
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.794 0.206
E03.8 Other specified hypothyroidism
0.000 0.806 0.194
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.853 0.147
E00-E07 Disorders of thyroid gland
0.000 0.939 0.061
E06 Thyroiditis
0.000 0.948 0.052
E06.3 Autoimmune thyroiditis
0.000 0.954 0.046
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.956 0.044
E00 Congenital iodine-deficiency syndrome
0.000 0.956 0.044
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.958 0.041
E06.9 Thyroiditis, unspecified
0.000 0.959 0.041
E07 Other disorders of thyroid
0.000 0.960 0.039
E06.4 Drug-induced thyroiditis
0.000 0.963 0.037
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.963 0.037
E06.0 Acute thyroiditis
0.000 0.963 0.037
E06.1 Subacute thyroiditis
0.000 0.966 0.033
E06.5 Other chronic thyroiditis
0.000 0.966 0.033
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.968 0.031
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.968 0.031
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.968 0.031
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.968 0.031
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.968 0.031
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.968 0.031
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.968 0.031
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.968 0.031
E04 Other non-toxic goitre
0.000 0.969 0.031
E07.8 Other specified disorders of thyroid
0.000 0.970 0.030
E07.1 Dyshormogenetic goitre
0.000 0.971 0.028
E07.0 Hypersecretion of calcitonin
0.000 0.971 0.028
C50.4 Upper-outer quadrant of breast
0.000 0.975 0.025
E04.2 Non-toxic multinodular goitre
0.000 0.975 0.025
E04.8 Other specified non-toxic goitre
0.000 0.977 0.023
E04.0 Non-toxic diffuse goitre
0.000 0.978 0.022
E07.9 Disorder of thyroid, unspecified
0.000 0.979 0.021
D34 Benign neoplasm of thyroid gland
0.021 0.979 0.000
E04.9 Non-toxic goitre, unspecified
0.000 0.980 0.020
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.980 0.020
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.017 0.983 0.000
E14.9 Without complications
0.000 0.984 0.016
E05.8 Other thyrotoxicosis
0.000 0.985 0.015
E05.5 Thyroid crisis or storm
0.000 0.985 0.014
E05.4 Thyrotoxicosis factitia
0.000 0.985 0.014
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.985 0.014
E05.9 Thyrotoxicosis, unspecified
0.000 0.986 0.014
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.013 0.987 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.987 0.012
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.012 0.988 0.000
C82.0 Small cleaved cell, follicular
0.011 0.989 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.011 0.989 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.011 0.989 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.010 0.989 0.000
E55.9 Vitamin D deficiency, unspecified
0.000 0.989 0.010
C82.4 Follicular lymphoma grade IIIb
0.010 0.990 0.000
E04.1 Non-toxic single thyroid nodule
0.000 0.990 0.010
C85.1 B-cell lymphoma, unspecified
0.010 0.990 0.000
E14 Unspecified diabetes mellitus
0.000 0.990 0.010
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.010 0.990 0.000
C85.0 Lymphosarcoma
0.010 0.990 0.000
C82.2 Large cell, follicular
0.010 0.990 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.010 0.990 0.000
C82.3 Follicular lymphoma grade IIIa
0.009 0.991 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.991 0.009
E55 Vitamin D deficiency
0.000 0.991 0.009
C82.1 Mixed small cleaved and large cell, follicular
0.009 0.991 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.991 0.009
C85.7 Other specified types of non-Hodgkin's lymphoma
0.009 0.991 0.000
C83.0 Small cell (diffuse)
0.009 0.991 0.000
C81 Hodgkin's disease
0.009 0.991 0.000
C82.6 Cutaneous follicle centre lymphoma
0.009 0.991 0.000
C82.5 Diffuse follicle centre lymphoma
0.009 0.991 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.009 0.991 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.991 0.009
C81.9 Hodgkin's disease, unspecified
0.009 0.991 0.000
C83.1 Small cleaved cell (diffuse)
0.009 0.991 0.000
E14.8 With unspecified complications
0.000 0.991 0.009
E50-E64 Other nutritional deficiencies
0.000 0.991 0.009
E10-E14 Diabetes mellitus
0.000 0.992 0.008
C83.3 Large cell (diffuse)
0.008 0.992 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.008 0.992 0.000
C94 Other leukaemias of specified cell type
0.008 0.992 0.000
C86 Other specified types of T/NK-cell lymphoma
0.008 0.992 0.000
C93 Monocytic leukaemia
0.008 0.992 0.000
C91 Lymphoid leukaemia
0.008 0.992 0.000
C83.7 Burkitt's tumour
0.008 0.992 0.000
C88 Malignant immunoproliferative diseases
0.008 0.992 0.000
C95 Leukaemia of unspecified cell type
0.008 0.992 0.000
C83.6 Undifferentiated (diffuse)
0.008 0.992 0.000
C83.5 Lymphoblastic (diffuse)
0.008 0.992 0.000
C83.4 Immunoblastic (diffuse)
0.008 0.992 0.000
C83.2 Mixed small and large cell (diffuse)
0.008 0.992 0.000
R19.8 Other specified symptoms and signs involving the digestive system and abdomen
0.008 0.992 0.000
E14.2 Withrenal complications
0.000 0.992 0.008
E14.7 With multiple complications
0.000 0.992 0.007
E14.5 With peripheral circulatory complications
0.000 0.992 0.007
E14.0 With coma
0.000 0.992 0.007
C81.2 Mixed cellularity
0.007 0.993 0.000
C91.0 Acute lymphoblastic leukaemia
0.007 0.993 0.000
C81.7 Other Hodgkin's disease
0.007 0.993 0.000
E55.0 Rickets, active
0.000 0.993 0.007
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.007 0.993 0.000
C81.3 Lymphocytic depletion
0.007 0.993 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.007 0.993 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.993 0.007
E14.1 With ketoacidosis
0.000 0.993 0.007
C90 Multiple myeloma and malignant plasma cell neoplasms
0.007 0.993 0.000
C91.9 Lymphoid leukaemia, unspecified
0.007 0.993 0.000
E58 Dietary calcium deficiency
0.000 0.993 0.007
E14.4 With neurological complications
0.000 0.993 0.006
E51 Thiamine deficiency
0.000 0.993 0.006
E13 Other specified diabetes mellitus
0.000 0.993 0.006
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.993 0.006
E63 Other nutritional deficiencies
0.000 0.993 0.006
E50 Vitamin A deficiency
0.000 0.993 0.006
E60 Dietary zinc deficiency
0.000 0.993 0.006
E59 Dietary selenium deficiency
0.000 0.993 0.006
E54 Ascorbic acid deficiency
0.000 0.993 0.006
E52 Niacin deficiency [pellagra]
0.000 0.993 0.006
C81.0 Lymphocytic predominance
0.006 0.994 0.000
E40-E46 Malnutrition
0.000 0.994 0.006
C84 Peripheral and cutaneous T-cell lymphomas
0.006 0.994 0.000
E12 Malnutrition-related diabetes mellitus
0.000 0.994 0.006
E61 Deficiency of other nutrient elements
0.000 0.994 0.006
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.006 0.994 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.006 0.994 0.000
C86.4 Blastic NK-cell lymphoma
0.006 0.994 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.006 0.994 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.006 0.994 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.006 0.994 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.006 0.994 0.000
C91.4 Hairy-cell leukaemia
0.006 0.994 0.000
C94.7 Other specified leukaemias
0.006 0.994 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.006 0.994 0.000
C94.5 Acute myelofibrosis
0.006 0.994 0.000
C94.4 Acute panmyelosis
0.006 0.994 0.000
C94.3 Mast cell leukaemia
0.006 0.994 0.000
C94.2 Acute megakaryoblastic leukaemia
0.006 0.994 0.000
C94.1 Chronic erythraemia
0.006 0.994 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.006 0.994 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.006 0.994 0.000
C96.8 Histiocytic sarcoma
0.006 0.994 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.006 0.994 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.006 0.994 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.006 0.994 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.006 0.994 0.000
C96.3 True histiocytic lymphoma
0.006 0.994 0.000
C96.2 Malignant mast cell tumour
0.006 0.994 0.000
C96.1 Malignant histiocytosis
0.006 0.994 0.000
C96.0 Letterer-Siwe disease
0.006 0.994 0.000
E14.3 With ophthalmic complications
0.000 0.994 0.006
C93.9 Monocytic leukaemia, unspecified
0.006 0.994 0.000
C93.7 Other monocytic leukaemia
0.006 0.994 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.006 0.994 0.000
C93.2 Subacute monocytic leukaemia
0.006 0.994 0.000
C93.0 Acute monocytic leukaemia
0.006 0.994 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.006 0.994 0.000
C91.7 Other lymphoid leukaemia
0.006 0.994 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.006 0.994 0.000
C91.3 Prolymphocytic leukaemia
0.006 0.994 0.000
C91.2 Subacute lymphocytic leukaemia
0.006 0.994 0.000
C93.1 Chronic monocytic leukaemia
0.006 0.994 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.006 0.994 0.000
C88.7 Other malignant immunoproliferative diseases
0.006 0.994 0.000
C88.3 Immunoproliferative small intestinal disease
0.006 0.994 0.000
C88.2 Gamma heavy chain disease
0.006 0.994 0.000
C88.1 Alpha heavy chain disease
0.006 0.994 0.000
E56 Other vitamin deficiencies
0.000 0.994 0.006
C95.7 Other leukaemia of unspecified cell type
0.006 0.994 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.006 0.994 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.006 0.994 0.000
C95.0 Acute leukaemia of unspecified cell type
0.006 0.994 0.000
C91.5 Adult T-cell leukaemia
0.006 0.994 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.006 0.994 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.006 0.994 0.000
W25.9 Unspecified place
0.006 0.994 0.000
E14.6 With other specified complications
0.000 0.994 0.005
C90.2 Plasmacytoma, extramedullary
0.006 0.994 0.000
C95.9 Leukaemia, unspecified
0.005 0.994 0.000
E11.9 Without complications
0.000 0.995 0.005
E65-E68 Obesity and other hyperalimentation
0.000 0.995 0.005
C81.1 Nodular sclerosis
0.005 0.995 0.000
C90.3 Solitary plasmacytoma
0.005 0.995 0.000
E15 Nondiabetic hypoglycaemic coma
0.000 0.995 0.005
E13.9 Without complications
0.000 0.995 0.005
C84.8 Cutaneous T-cell lymphoma, unspecified
0.005 0.995 0.000
E11.2 With renal complications
0.000 0.995 0.005
E51.2 Wernicke's encephalopathy
0.000 0.995 0.005
E61.2 Magnesium deficiency
0.000 0.995 0.005
C84.0 Mycosis fungoides
0.005 0.995 0.000
E51.9 Thiamine deficiency, unspecified
0.000 0.995 0.005
E51.8 Other manifestations of thiamine deficiency
0.000 0.995 0.005
E51.1 Beriberi
0.000 0.995 0.005
E13.8 With unspecified complications
0.000 0.995 0.005
E13.7 With multiple complications
0.000 0.995 0.005
E13.6 With other specified complications
0.000 0.995 0.005
E13.5 With peripheral circulatory complications
0.000 0.995 0.005
E13.4 With neurological complications
0.000 0.995 0.005
E13.3 With ophthalmic complications
0.000 0.995 0.005
E13.2 With renal complications
0.000 0.995 0.005
E13.1 With ketoacidosis
0.000 0.995 0.005
E13.0 With coma
0.000 0.995 0.005
E16 Other disorders of pancreatic internal secretion
0.000 0.995 0.005
E50.9 Vitamin A deficiency, unspecified
0.000 0.995 0.005
E50.8 Other manifestations of vitamin A deficiency
0.000 0.995 0.005
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.995 0.005
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.995 0.005
E50.5 Vitamin A deficiency with night blindness
0.000 0.995 0.005
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.995 0.005
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.995 0.005
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.995 0.005
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.995 0.005
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.995 0.005
E63.9 Nutritional deficiency, unspecified
0.000 0.995 0.005
E63.8 Other specified nutritional deficiencies
0.000 0.995 0.005
E63.1 Imbalance of constituents of food intake
0.000 0.995 0.005
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.995 0.005
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.995 0.005
E64.8 Sequelae of other nutritional deficiencies
0.000 0.995 0.005
E64.3 Sequelae of rickets
0.000 0.995 0.005
E64.2 Sequelae of vitamin C deficiency
0.000 0.995 0.005
E64.1 Sequelae of vitamin A deficiency
0.000 0.995 0.005
E64.0 Sequelae of protein-energy malnutrition
0.000 0.995 0.005
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.995 0.005
E45 Retarded development following protein-energy malnutrition
0.000 0.995 0.005
E43 Unspecified severe protein-energy malnutrition
0.000 0.995 0.005
E42 Marasmic kwashiorkor
0.000 0.995 0.005
E41 Nutritional marasmus
0.000 0.995 0.005
E40 Kwashiorkor
0.000 0.995 0.005
C84.9 Mature T/NK-cell lymphoma, unspecified
0.005 0.995 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.005 0.995 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.005 0.995 0.000
C84.3 Lymphoepithelioid lymphoma
0.005 0.995 0.000
C84.2 T-zone lymphoma
0.005 0.995 0.000
C84.1 Sezary's diease
0.005 0.995 0.000
C90.1 Plasma cell leukaemia
0.005 0.995 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.995 0.005
E12.9 Without complications
0.000 0.995 0.005
E12.8 With unspecified complications
0.000 0.995 0.005
E12.7 With multiple complications
0.000 0.995 0.005
E12.6 With other specified complications
0.000 0.995 0.005
E12.5 With peripheral circulatory complications
0.000 0.995 0.005
E12.4 With neurological complications
0.000 0.995 0.005
E12.3 With ophthalmic complications
0.000 0.995 0.005
E12.2 With renal complications
0.000 0.995 0.005
E12.1 With ketoacidosis
0.000 0.995 0.005
E12.0 With coma
0.000 0.995 0.005
E61.9 Deficiency of nutrient element, unspecified
0.000 0.995 0.005
E61.8 Deficiency of other specified nutrient elements
0.000 0.995 0.005
E61.7 Deficiency of multiple nutrient elements
0.000 0.995 0.005
E61.6 Vanadium deficiency
0.000 0.995 0.005
E61.5 Molybdenum deficiency
0.000 0.995 0.005
E61.4 Chromium deficiency
0.000 0.995 0.005
E61.3 Manganese deficiency
0.000 0.995 0.005
E61.0 Copper deficiency
0.000 0.995 0.005
E56.9 Vitamin deficiency, unspecified
0.000 0.995 0.004
E56.8 Deficiency of other vitamins
0.000 0.995 0.004
E56.0 Deficiency of vitamin E
0.000 0.995 0.004
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.005 0.995 0.000
R19.0 Intra-abdominal and pelvic swelling, mass and lump
0.004 0.996 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.996 0.004
D22.6 Melanocytic naevi of upper limb, including shoulder
0.000 0.996 0.004
E46 Unspecified protein-energy malnutrition
0.000 0.996 0.004
C84.4 Peripheral T-cell lymphoma
0.004 0.996 0.000
E53 Deficiency of other B group vitamins
0.000 0.996 0.004
E67 Other hyperalimentation
0.000 0.996 0.004
E68 Sequelae of hyperalimentation
0.000 0.996 0.004
E56.1 Deficiency of vitamin K
0.000 0.996 0.004
W25 Contact with sharp glass
0.004 0.996 0.000
E61.1 Iron deficiency
0.000 0.996 0.004
Z91.6 Personal history of other physical trauma
0.000 0.996 0.004
C92 Myeloid leukaemia
0.004 0.996 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.996 0.004
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.996 0.004
E16.4 Abnormal secretion of gastrin
0.000 0.996 0.004
E16.3 Increased secretion of glucagon
0.000 0.996 0.004
E44.1 Mild protein-energy malnutrition
0.000 0.996 0.003
E44.0 Moderate protein-energy malnutrition
0.000 0.996 0.003
E11.7 With multiple complications
0.000 0.996 0.004
E16.1 Other hypoglycaemia
0.000 0.996 0.004
M51.0 Lumbar and other intervertebral disk disorders with myelopathy
0.004 0.996 0.000
C45 Mesothelioma
0.004 0.996 0.000
C45.7 Mesothelioma of other sites
0.004 0.996 0.000
J38.3 Other diseases of vocal cords
0.004 0.996 0.000
C45.9 Mesothelioma, unspecified
0.004 0.996 0.000
E11.8 With unspecified complications
0.000 0.996 0.003
E11.3 With ophthalmic complications
0.000 0.996 0.004
E65 Localised adiposity
0.000 0.997 0.003
C45.0 Mesothelioma of pleura
0.003 0.997 0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.003 0.997 0.000
W25.8 Other specified place
0.003 0.997 0.000
G25.0 Essential tremor
0.003 0.997 0.000
Z98.8 Other specified postsurgical states
0.003 0.997 0.000
C84.5 Other and unspecified T-cell lymphomas
0.003 0.997 0.001
E53.1 Pyridoxine deficiency
0.000 0.997 0.003
E53.0 Riboflavin deficiency
0.000 0.997 0.003
E66 Obesity
0.000 0.997 0.003
E67.8 Other specified hyperalimentation
0.000 0.997 0.003
E67.3 Hypervitaminosis D
0.000 0.997 0.003
E67.2 Megavitamin-B6 syndrome
0.000 0.997 0.003
E67.1 Hypercarotenaemia
0.000 0.997 0.003
E67.0 Hypervitaminosis A
0.000 0.997 0.003
N31.9 Neuromuscular dysfunction of bladder, unspecified
0.003 0.997 0.000
Z48.8 Other specified surgical follow-up care
0.003 0.997 0.000
W25.6 Industrial and construction area
0.003 0.997 0.000
W25.5 Trade and service area
0.003 0.997 0.000
W25.1 Residential institution
0.003 0.997 0.000
W25.0 Home
0.003 0.997 0.000
W25.7 Farm
0.003 0.997 0.000
W25.4 Street and highway
0.003 0.997 0.000
W25.3 Sports and athletics area
0.003 0.997 0.000
W25.2 School, other institution and public administrative area
0.003 0.997 0.000
R19 Other symptoms and signs involving the digestive system and abdomen
0.003 0.997 0.000
C91.1 Chronic lymphocytic leukaemia
0.003 0.997 0.000
I44.7 Left bundle-branch block, unspecified
0.000 0.997 0.003
C92.9 Myeloid leukaemia, unspecified
0.003 0.997 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.003 0.997 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.003 0.997 0.000
C92.5 Acute myelomonocytic leukaemia
0.003 0.997 0.000
C92.3 Myeloid sarcoma
0.003 0.997 0.000
C92.2 Subacute myeloid leukaemia
0.003 0.997 0.000
L05.0 Pilonidal cyst with abscess
0.000 0.997 0.003
S01.1 Open wound of eyelid and periocular area
0.003 0.997 0.000
D69.3 Idiopathic thrombocytopenic purpura
0.003 0.997 0.000
E11.0 With coma
0.000 0.997 0.003
R19.6 Halitosis
0.003 0.997 0.000
C92.4 Acute promyelocytic leukaemia
0.003 0.997 0.000
E20-E35 Disorders of other endocrine glands
0.000 0.997 0.003
C45.2 Mesothelioma of pericardium
0.003 0.997 0.000
C45.1 Mesothelioma of peritoneum
0.003 0.997 0.000
E11.1 With ketoacidosis
0.000 0.997 0.003
C92.7 Other myeloid leukaemia
0.003 0.997 0.000
E66.9 Obesity, unspecified
0.000 0.997 0.003
E29 Testicular dysfunction
0.000 0.997 0.003
E29.1 Testicular hypofunction
0.000 0.997 0.003
E53.9 Vitamin B deficiency, unspecified
0.000 0.997 0.003
K91.3 Postoperative intestinal obstruction
0.003 0.997 0.000
C90.0 Multiple myeloma
0.003 0.997 0.000
E20 Hypoparathyroidism
0.000 0.997 0.003
E88 Other metabolic disorders
0.003 0.997 0.000
C49.2 Connective and soft tissue of lower limb, including hip
0.003 0.997 0.000
E66.0 Obesity due to excess calories
0.000 0.997 0.003
E87.7 Fluid overload
0.003 0.997 0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.003 0.997 0.000
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.997 0.003
E66.1 Drug-induced obesity
0.000 0.997 0.002
W25.09 Contact with sharp glass; Home; During unspecified activity
0.002 0.997 0.000
W25.03 Contact with sharp glass; Home; While engaged in other types of work
0.002 0.997 0.000
W25.18 Contact with sharp glass; Residential institution;While engaged in other specified activities
0.002 0.997 0.000
W25.52 Contact with sharp glass; Trade and service area;While working for income
0.002 0.997 0.000
W25.62 Contact with sharp glass; Industrial and construction area ;While working for income
0.002 0.997 0.000
E20.9 Hypoparathyroidism, unspecified
0.000 0.997 0.002
K91.0 Vomiting following gastro-intestinal surgery
0.003 0.997 0.000
M25.85 Other specified joint disorders (Pelvic region and thigh)
0.000 0.997 0.003
R19.3 Abdominal rigidity
0.002 0.997 0.000
R19.1 Abnormal bowel sounds
0.002 0.997 0.000
E16.2 Hypoglycaemia, unspecified
0.000 0.997 0.003
E88.8 Other specified metabolic disorders
0.002 0.997 0.000
A04.5 Campylobacter enteritis
0.000 0.997 0.003
C49 Malignant neoplasm of other connective and soft tissue
0.002 0.998 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.002 0.998 0.000
E34.8 Other specified endocrine disorders
0.000 0.998 0.002
W49 Exposure to other and unspecified inanimate mechanical forces
0.002 0.998 0.000
R19.2 Visible peristalsis
0.002 0.998 0.000
Y85.9 Sequelae of other and unspecified transport accidents
0.002 0.998 0.000
E34 Other endocrine disorders
0.000 0.998 0.002
H72.0 Central perforation of tympanic membrane
0.002 0.998 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.998 0.002
E32 Diseases of thymus
0.000 0.998 0.002
E30 Disorders of puberty, not elsewhere classified
0.000 0.998 0.002
E25 Adrenogenital disorders
0.000 0.998 0.002
C48.2 Peritoneum, unspecified
0.002 0.998 0.000
N93.8 Other specified abnormal uterine and vaginal bleeding
0.002 0.998 0.000
E21.0 Primary hyperparathyroidism
0.000 0.998 0.002
E24 Cushing's syndrome
0.000 0.998 0.002
W20-W49 Exposure to inanimate mechanical forces
0.002 0.998 0.000
E88.3 Tumour lysis syndrome
0.002 0.998 0.000
C49.1 Connective and soft tissue of upper limb, including shoulder
0.002 0.998 0.000
E29.9 Testicular dysfunction, unspecified
0.000 0.998 0.002
E29.8 Other testicular dysfunction
0.000 0.998 0.002
E29.0 Testicular hyperfunction
0.000 0.998 0.002
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.998 0.002
H34.8 Other retinal vascular occlusions
0.000 0.998 0.002
E26 Hyperaldosteronism
0.000 0.998 0.002
E88.2 Lipomatosis, not elsewhere classified
0.002 0.998 0.000
E31 Polyglandular dysfunction
0.000 0.998 0.002
K91.2 Postsurgical malabsorption, not elsewhere classified
0.002 0.998 0.000
W49.9 Unspecified place
0.002 0.998 0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms
0.002 0.998 0.000
E20.8 Other hypoparathyroidism
0.000 0.998 0.002
E20.1 Pseudohypoparathyroidism
0.000 0.998 0.002
E20.0 Idiopathic hypoparathyroidism
0.000 0.998 0.002
E88.9 Metabolic disorder, unspecified
0.002 0.998 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.998 0.002
W24 Contact with lifting and transmission devices, not elsewhere classified
0.002 0.998 0.000
W49.6 Industrial and construction area
0.002 0.998 0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.002 0.998 0.000
W23 Caught, crushed, jammed or pinched in or between objects
0.002 0.998 0.000
W24.6 Industrial and construction area
0.002 0.998 0.000
W49.0 Home
0.002 0.998 0.000
K91.5 Postcholecystectomy syndrome
0.002 0.998 0.000
K91.1 Postgastric surgery syndromes
0.002 0.998 0.000
C49.5 Connective and soft tissue of pelvis
0.002 0.998 0.000
E11.6 With other specified complications
0.001 0.998 0.001
Q05.9 Spina bifida, unspecified
0.002 0.998 0.000
E28 Ovarian dysfunction
0.000 0.998 0.002
C49.4 Connective and soft tissue of abdomen
0.002 0.998 0.000
E24.9 Cushing's syndrome, unspecified
0.000 0.998 0.002
W40 Explosion of other materials
0.002 0.998 0.000
E88.1 Lipodystrophy, not elsewhere classified
0.002 0.998 0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.002 0.998 0.000
C46 Kaposi's sarcoma
0.002 0.998 0.000
C49.8 Overlapping lesion of connective and soft tissue
0.002 0.998 0.000
C49.6 Connective and soft tissue of trunk, unspecified
0.002 0.998 0.000
W23.4 Street and highway
0.002 0.998 0.000
S82.20 Fracture of shaft of tibia (closed)
0.000 0.998 0.002
E11.5 With peripheral circulatory complications
0.000 0.998 0.002
K85.8 Other acute pancreatitis
0.002 0.998 0.000
E34.5 Androgen resistance syndrome
0.000 0.998 0.002
E34.4 Constitutional tall stature
0.000 0.998 0.002
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.998 0.002
E34.1 Other hypersecretion of intestinal hormones
0.000 0.998 0.002
W49.8 Other specified place
0.002 0.998 0.000
W49.7 Farm
0.002 0.998 0.000
W49.5 Trade and service area
0.002 0.998 0.000
W49.4 Street and highway
0.002 0.998 0.000
W49.3 Sports and athletics area
0.002 0.998 0.000
W49.2 School, other institution and public administrative area
0.002 0.998 0.000
W49.1 Residential institution
0.002 0.998 0.000
H71 Cholesteatoma of middle ear
0.002 0.998 0.000
M25.84 Other specified joint disorders (Hand)
0.000 0.998 0.002
M25.81 Other specified joint disorders (Shoulder region)
0.000 0.998 0.002
E21.3 Hyperparathyroidism, unspecified
0.000 0.998 0.002
E34.0 Carcinoid syndrome
0.000 0.998 0.002
K91.9 Postprocedural disorder of digestive system, unspecified
0.002 0.998 0.000
W26 Contact with knife, sword or dagger
0.002 0.998 0.000
E25.9 Adrenogenital disorder, unspecified
0.000 0.998 0.002
E25.8 Other adrenogenital disorders
0.000 0.998 0.002
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.998 0.002
E30.9 Disorder of puberty, unspecified
0.000 0.998 0.002
E30.8 Other disorders of puberty
0.000 0.998 0.002
E30.1 Precocious puberty
0.000 0.998 0.002
E30.0 Delayed puberty
0.000 0.998 0.002
E32.9 Disease of thymus, unspecified
0.000 0.998 0.002
E32.8 Other diseases of thymus
0.000 0.998 0.002
E32.1 Abscess of thymus
0.000 0.998 0.002
E32.0 Persistent hyperplasia of thymus
0.000 0.998 0.002
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.998 0.002
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.998 0.002
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.998 0.002
D10.1 Tongue
0.002 0.998 0.000
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)
0.002 0.998 0.000
E24.8 Other Cushing's syndrome
0.000 0.998 0.002
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.998 0.002
E24.3 Ectopic ACTH syndrome
0.000 0.998 0.002
E24.1 Nelson's syndrome
0.000 0.998 0.002
W40.9 Unspecified place
0.002 0.998 0.000
W46 Contact with hypodermic needle
0.002 0.998 0.000
W43 Exposure to vibration
0.002 0.998 0.000
W42 Exposure to noise
0.002 0.998 0.000
W41 Exposure to high-pressure jet
0.002 0.998 0.000
W39 Discharge of firework
0.002 0.998 0.000
W38 Explosion and rupture of other specified pressurised devices
0.002 0.998 0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose
0.002 0.998 0.000
W36 Explosion and rupture of gas cylinder
0.002 0.998 0.000
W35 Explosion and rupture of boiler
0.002 0.998 0.000
W34 Discharge from other and unspecified firearms
0.002 0.998 0.000
W33 Rifle, shotgun and larger firearm discharge
0.002 0.998 0.000
W32 Handgun discharge
0.002 0.998 0.000
W31 Contact with other and unspecified machinery
0.002 0.998 0.000
W30 Contact with agricultural machinery
0.002 0.998 0.000
M25.8 Other specified joint disorders
0.000 0.998 0.002
M67.1 Other contracture of tendon (sheath)
0.002 0.998 0.000
W27 Contact with nonpowered hand tool
0.002 0.998 0.000
E21.2 Other hyperparathyroidism
0.000 0.998 0.002
E26.9 Hyperaldosteronism, unspecified
0.000 0.998 0.002
E26.8 Other hyperaldosteronism
0.000 0.998 0.002
E26.1 Secondary hyperaldosteronism
0.000 0.998 0.002
W23.2 School, other institution and public administrative area
0.002 0.998 0.000
Z00.0 General medical examination
0.002 0.998 0.000
W29 Contact with other powered hand tools and household machinery
0.002 0.998 0.000
E31.9 Polyglandular dysfunction, unspecified
0.000 0.998 0.002
E31.8 Other polyglandular dysfunction
0.000 0.998 0.002
E31.1 Polyglandular hyperfunction
0.000 0.998 0.002
W44 Foreign body entering into or through eye or natural orifice
0.002 0.998 0.000
I30.9 Acute pericarditis, unspecified
0.000 0.998 0.002
W24.8 Other specified place
0.002 0.998 0.000
W24.7 Farm
0.002 0.998 0.000
W24.5 Trade and service area
0.002 0.998 0.000
W24.4 Street and highway
0.002 0.998 0.000
W24.3 Sports and athletics area
0.002 0.998 0.000
W24.2 School, other institution and public administrative area
0.002 0.998 0.000
W24.1 Residential institution
0.002 0.998 0.000
W24.0 Home
0.002 0.998 0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum
0.002 0.998 0.000
E11.4 With neurological complications
0.000 0.998 0.002
E24.0 Pituitary-dependent Cushing's disease
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.